TY  - JOUR
PY  - 2024//
TI  - The importance of co-produced, multi-method, independent scientific evidence in times of alternative truths and global policy debates
JO  - International journal on drug policy
A1  - Comiskey, Catherine
A1  - Bergeron, Henri
A1  - Clausen, Thomas
A1  - Colman, Charlotte
A1  - Ferrer-Wreder, Laura
A1  - Fischer, Gabriele
A1  - de Matos, Margarida Gaspar
A1  - Ivers, Jo-Hanna
A1  - Jauffret-Roustide, Marie
A1  - Liem, Marieke
A1  - Lintonen, Tomi
A1  - Moeller, Kim
A1  - Ojanperä, Ilkka
A1  - de Fonseca, Fernando Rodríguez
A1  - Mèlich, Marta Torrens
SP  - e104481
EP  - e104481
VL  - 129
IS  - 
N2  - In July 2024 the long established and trusted European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) will cease to exist and will evolve to the new European Drugs Agency (EUDA). In response to the ever diversifying, innovative and complex drug phenomena, the EUDA will open with considerably more powers, new methodological tools, and a proactive remit to support preparedness, monitoring and competence development of policy makers, practitioners and researchers (EMCDDA, 2024). This expanded mandate includes threat assessments and alerts; monitoring and addressing poly-substance use; setting up a network of forensic laboratories; developing and promoting best practice; supporting independent evaluation of drug polices and playing a stronger international role within this remit in the EU. As the old adage coined by notaries from Voltaire to Spiderman have said, "with great power comes great responsibility", and it is in times of global policy pressure from so called 'fake news' to Artificial Intelligence generated data and conspiracy theories that the need for trusted, independent scientific evidence has never been greater.<p />  <p>Language: en</p>
LA  - en
SN  - 0955-3959
UR  - http://dx.doi.org/10.1016/j.drugpo.2024.104481
ID  - ref1
ER  -